All times shown are PDT (GMT-7) (San Francisco)
Displaying One Session
Abstract Sessions On-Demand Channel
Oral abstract session
Room
Abstract Sessions On-Demand Channel
Oral abstract session
Introduction
Speaker
Session Name
Room
Abstract Sessions On-Demand Channel
Oral abstract session
Analysis of protocol defined virologic failure through week 48 from a phase 2 trial (P011) of islatravir and doravirine in treatment-naïve adults with HIV-1 infection
Session Name
Room
Abstract Sessions On-Demand Channel
Oral abstract session
Adherence and factors associated with virologic success in HIV-1 infected adults with tuberculosis receiving raltegravir or efavirenz in the ANRS 12300 Reflate TB2 trial
Session Name
Room
Abstract Sessions On-Demand Channel
Oral abstract session
Reducing ART to less than 3-ARV regimen linked to increased systemic inflammation
Session Name
Room
Abstract Sessions On-Demand Channel
Oral abstract session
Islatravir safety analysis through week 48 from a phase 2 trial in treatment naïve adults with HIV-1 infection
Session Name
Room
Abstract Sessions On-Demand Channel
Oral abstract session
Conclusion
Speaker
Session Name
Room
Abstract Sessions On-Demand Channel